Numworks is a graphic calculator that aims to revolutionise the learning of mathematics through accessibility and Python code programming
Now the students have an extra weapon. Italian students who will have to take this year’s exam will be able to take the maths and physics tests with the help of Numworks. This is an innovative graphic calculator developed by the French company of the same name. The special feature of Numworks is its accessibility. The device has a larger colour screen than normal calculators. In addition to the traditional keys, there are special icons that facilitate operations and allow very intuitive use. Students will be able to perform simple calculations, operations between matrices and fractions, solve equations but also draw graphs and tables. All in a few seconds and with simple steps. Numworks is equipped with a USB connection and a rechargeable battery that ensures 20 hours of use.
Read also → ZimaBoard, the personal desktop server
Numworks: the calculator for the baccalaureate exam
Numworks is designed to facilitate the learning of mathematics for students with learning difficulties or dyscalculia. Numworks is also the first calculator in the Python programming language. Thanks to the Creative Commons licence, students and teachers can propose or report new features: just access the calculator’s programming code for free to make changes or share improvements with the rest of the community. At a time when the education sector is going through such a delicate and particular situation,” explained NumWorks founder and CEO Romain Goyet, “we believe that our calculator can provide concrete support to teachers and students in teaching and learning mathematics, helping them to excel in this extremely fascinating subject. It is no coincidence that the Numworks graphing calculator has been included by the Italian Ministry of Education in the list of devices admitted for the 2021 baccalaureate exam.
You might also be interested in → 20 years of Wikipedia. Curiosities about the most famous encyclopaedia in the world
Italy’s patent market ripe for harvest
The north of Italy has a long industrial heritage. Factories and skyscrapers jostle for space along the skyline, which sweeps from the western city of Turin across to the metropolis of Milan, and down into the canals of Venice. This region, and Italy’s northernmost cities, is also home to some of the country’s – and increasingly Europe’s – most important patent courts.
The prominence of the intellectual property sector in this region is not surprising. A nation of inventors, Italy has a proud tradition of protecting its goods, and preserving its scientific and artistic heritage. Years of patent litigation surround its famed espresso coffee machine, first patented in 1884 by Angelo Moriondo in Turin.
But Italy has faced several obstacles conspiring to constrain future innovation in the region. The patent court system is fragmented. Italy’s smaller enterprises regularly appear in one of 21 IP courts to defend their products; legislation dictates each region must have a specialist IP court. Lawyers cite poor English language skills among Italy’s old guard of patent lawyers as strained at best. The economy, which has long fluctuated, has never particularly favoured advancing its IP sytem. At first glance, Italy’s future in patent litigation seems in disarray.
History of pharma
Italy, however, is also home to several global pharmaceutical company headquarters, including leading names Menarini and Chiesi. Indeed, the country regularly ranks in the top ten global producers of pharmaceuticals. According to the Statistica website, the country is the largest producer of pharmaceuticals in Europe, worth a production value of 32 billion euros in 2018.
As such, the country regularly plays host to pan-European battles between major global pharmaceutical players. Disputes between leading generics and originators, such as Gilead, Teva and Hexal over HIV blockbuster drug Truvada, are playing out in Milan.
High-profile cases concerning erectile dysfunction drug tadalafil, and chemotherapy drug pemetrexed, are seeing high-stakes litigation. In fact, Italian patent courts play a role in all major European pharmaceutical disputes. This is either due the importance of the Italian market for the manufacturer, or because it is the country which produces the disputed product.
Milano to Turin
However, in pan-European pharmaceutical and biosimilar disputes, parties choose the Italian patent courts for strategic reasons. Particularly the patent court in Milan, presided over by judge Claudio Marangoni, is considered highly competent in pharmaceutical disputes.
The possibility of obtaining a preliminary injunction relatively quickly is a strategic advantage. Another plus is that the Italian courts conduct PI proceedings as if they were main proceedings, also examining patent validity. Obtaining a favourable decision can be advantageous for proceedings in other countries.
This type of PI proceeding was conducted by Bayer against Ceva for infringement of a medical veterinary preparation to treat piglets. The case is now one of the most extensive patent battles in Europe.
Companies also approach Italian courts when the sales market is interesting, as is the case with emerging ‘heat not burn’ e-cigarette technology. British American Tobacco (BAT) and Philip Morris are now fighting in Italy, as well as in Germany and the UK. The same applies to heart valve manufacturers, with Edwards Lifescience and Meril Life Sciences currently engaged in an intense dispute.
NPE Sisvel is also taking action in its home country against Chinese mobile phone manufacturers such as Xiaomi, Oppo and One Plus. “SEP disputes currently play a minor role in Italy,” confirm patent litigators from Italy’s patent practices. “Pharma disputes far outweigh SEP disputes, and Italy imports most of the cases,” says an IP partner at a full-service firm. “There are very few disputes between Italian manufacturers.”
An example is the dispute between the two manufacturers of motorcyclist clothing, fought over innovative airbags, until the parties settled last autumn. The dispute started in Italy, and then spread across Europe.
Winds of change
Despite its importance, Italy’s IP courts have seen minimal governmental investment. Traditionally, say patent lawyers, the sector was side-lined. But now patent firms are hopeful that changing governance and a reshuffle of Europe’s patent system could push Italy in the right direction.
The Italian government is currently experiencing a transition of power. In January 2021, a withdrawal of support in the coalition ended prime minster Giuseppe Conte’s term of office. At the time of writing, former European Central Bank president Mario Draghi is on the cusp of being elected Italy’s next prime minister.
Many circles – including among the patent lawyers interviewed by JUVE Patent – welcome Draghi. He is well-respected among Italy’s economists and politicians alike, with the country’s stock market responding buoyantly to his potential election.
Italy’s lawyers hope the dawn of a Draghi government meaning more targeted investment. For example, the burgeoning government has promised to invest three billion euros, over several years, into the Italian judiciary. Lawyers have even cautiously suggested that, should the upward economic trajectory continue, the country could fill a vacuum in pan-European patent law left by the UK.
Draghi’s new approach
IP boutique Trevisan & Cuonzo is currently very visible at the Italian courts, representing numerous companies in a variety of patent cases. It is public that the boutique acts for Ceva in the Italian branch of litigation against Bayer, and represents Xiaomi, Oppo and OnePlus against Sisvel.
The firm is also active for BAT against Philip Morris over e-cigarettes. Bonelli Erede represents Philip Morris.
Now Gabriel Cuonzo, co-founder of Italian IP boutique Trevisan & Cuonzo, and Vittorio Cerulli Irelli, partner and head of its Rome office, are exercising what they describe as “cautious optimism” about the future of Italy’s patent market.
“Italy is planning to invest a lot of money in the coming years. The top priority for the new prime minister will be to increase the efficiency of the judiciary,” says Cuonzo.
“This could help Milan become a European hub. It is already the Düsseldorf of Italy, but we expect its relevance in international litigation to increase in the medium term.”
Giovanni Galimberti is one of two patent litigation partners at the Milan office of Bird & Bird, alongside two other partners dealing with patent issues. For him, Italy’s future in patent law is bright.
“When people think of Italy, they think of the scenery, the art, the culture and the history,” he says. “Patent law is not necessarily the thing at the forefront of their mind. But Italy has the second highest number of patent cases in Europe, after Germany.”
He says, “With so many cases, its booming life sciences sector and a potential UPC court, the country’s potential as a core patent litigation location is being realised.”
But with an increase in market potential comes a rapidly-changing market structure. At the top of the market, IP boutiques are beginning to make way for international law firms.
Up until the past decade, a handful of well-respected IP professors and their associated firms led litigation procedures in Italy. Then, ten years ago, the numbers of specialist professors began to dwindle.
A handful of IP boutiques led by well-respected professors, such as Mario Franzosi, Adriano Vanzetti, Giuseppe Sena and Cesare Galli, do remain.
But as boutiques began to lessen their grip, European firms began to expand their reach across Italy and the continent.
Milan’s latest arrival in 2018 was Herbert Smith Freehills, with the Italian offices of Bird & Bird and Hogan Lovells already present in the market and visible in major disputes, such as Bird & Bird appearing for Sisvel against various Chinese handset manufacturers.
Bird & Bird also represents Edwards Lifescience in various European jurisdictions against Meril, including Italy. It is publicly known that Hogan Lovells is active for Meril. The patent team also has an intense relationship with pharma giant Eli Lilly in Italy, as well in the UK and Germany.
Over the past few years, the market has also welcomed DLA Piper and Simmons & Simmons.
As the system modernised, international and European firms seized an opportunity to establish themselves in patent hotspots of Milan, Turin and Rome. Patent lawyers in larger firms argue that a greater variety better positions Italy to export its patent expertise.
Stefania Bergia, IP partner at the Milan office of Simmons & Simmons, says, “Pan-European litigation gives us a chance to work with colleagues in another branch of our own firm. Both litigation and advisory services increasingly require across-the-board solutions, which it was becoming difficult to find in boutique firms. Instead, lawyers in international firms can combine their expertise. This is what clients are looking for.”
New piece of the puzzle
Other international firms have recently worked on expanding their reach beyond Europe’s main patent jurisdictions. For firms domiciled in the UK, Brexit means looking for reinforcement in key court locations.
Laura Orlando is the managing partner of Herbert Smith Freehills’ patent practice in Milan, which she co-founded with partner Sebastian Moore in 2018. For Orlando, the move presented an opportunity to provide a well-established UK firm, which recently opened an IP practice in Germany, with an additional strong presence in Italy.
“We’re acting as a hub for global co-ordination work,” says Orlando. “Herbert Smith Freehills realised that, after Brexit, it couldn’t be a solo outfit, so the Milan office is part of a wider push across Europe.”
“The big cases are frequently litigated in Italy, and its lawyers are technically very talented. The Italian market has long been dominated by boutiques built around charismatic founders. However, now there is a real demand by multinationals experienced in global patent litigation for institutionalised representation.”
From the beginning of its launch in Milan, Herbert Smith Freehills’ most prominent client was Gilead in the Truvada case against various generics companies. Different Italian IP boutiques represented generics.
Sebastian Moore is also representing Gilead in the UK case, and co-ordinates the pan-European Truvada litigation.
Bright young things
Italy’s generational shift also plays a role in its patent firms offering fresh opportunities for law graduates.
Giulio Sironi, another patent partner at Simmons & Simmons, says, “Many young lawyers are interested in the international firm experience. Firms with pan-European offices and a more global structure can offer experience in other countries, as well as secondments with clients. This helps the new generation of practitioners to be more in-tune with client needs.”
On the other hand, boutiques such as Trevisan & Cuonzo and Galli still flourish. The large numbers of IP conflicts running in Italy means there is more than enough work to go around.
A promise of increased investment in the patent sector means firms are beginning to showcase their European potential. Leading IP boutiques are no exception.
As investment in the Italian patent market increases, so too will interest in working for a well-connected patent firm. To continue attracting young talent, Italian boutiques must establish good links with other European independent practices. Such cross-border support could secure their future.
And the new generation of Italian lawyers reaches beyond just patent litigators.
Firms praise the “good young judges” emerging across Italy’s top patent courts, gradually replacing an old guard moving to pastures new.
Many patent lawyers note that Italy’s previous judicial bench found speaking English a stumbling block. Naturally, this had repercussions on the courts’ ability to truly integrate in the European system. Not just in terms of ability to conduct cases, but also the judiciary’s ability to market and showcase its patent judge expertise to the world.
Now, however, this is changing. Vittorio Cerulli Irelli says, “It’s refreshing to have a panel of young judges in Milan with a highly-practical attitude. We are seeing this approach in a number of high-stake FRAND cases we are handling, raising a lot of case management complexities.”
“Also, they are making excellent use of the new technologies which have become available as a consequence of the pandemic. It is now common practice to have online hearings with parties, foreign counsel and experts joining from abroad, with simultaneous translation,” says Cerulli Irelli.
A recent effort to streamline proceedings is also addressing this problem. Laura Orlando says, “There has been a perception of the Italian courts being slow, whereas today the specialised IP sections are efficient and speedy forums in which to litigate patents. The efficiency of the specialised IP courts is helped greatly by the high quality of its judges.”
For Gualtiero Dragotti, partner at the Milan office of DLA Piper, the main draw of Italy’s courts is strategic. Dragotti represented Alpinestar in the Italian case against competitor Dainese. He argues that the country’s courts offer something different to Europe’s other leading jurisdictions.
He says, “You go to the Netherlands for a cross-border injunction, Germany for an injunction, and the UK for damages. You’d come to Italy if you want a validity and infringement decision from the same judge.”
Massimiliano Mostardini, partner at Bird & Bird’s Milan office, says, “Parties often choose Italy for strategic reasons. Whether it’s a torpedo, preliminary injunction, the saisie-contrefaçon (descrizione in Italian), or because the courts here are cheaper. It’s a big market, and we have a lot to offer.”
Veil of secrecy
Italian court continues to operate in a clandestine manner. Law firms are often unaware who is representing the opposing party; hearings take place before the judge in a closed room. Efficient proceedings on the merits are undoubtedly a boon for a sector still unknown to most of its European counterparts.
Some lawyers worry that, until this changes, Italy cannot be a viable option for clients. Here, other European courts such as the UK and the Netherlands clearly have a more transparent case management process. But Italy is working to throw off these shackles with other techniques.
As well as streamlining its procedures, patent lawyers say the coronavirus pandemic has led to a willingness by Italian courts to be open to new ideas.
Stefania Bergia says, “At the beginning of COVID-19, the courts physically shut down due to a lack of technological adoption. Over the past year, there has been an increasing adoption of IT tools. For example, court hearings can now be held over standard online platforms. This allows us to use the convenient functions of these platforms, including screen sharing during hearings.”
Bergia says, “This increasing technological innovation – in addition to creating a more efficient and rapid justice system – will serve to ensure that any urgent and emergency circumstances in the future will allow the justice system to move forward seamlessly.”
Italy’s patent judges are also increasing their visibility in the European patent market. Leading IP courts such as Milan, Turin and Rome turnover most of Italy’s patent cases. Venice hosts the annual Intellectual Property Conference. Patent lawyers frequently mention the impressive work of judges such as Claudio Marangoni, Silvia Vitrò and Umberto Scotti.
Simple as UPC
An increase in judicial transparency has also opened the door for discussions around Italy’s hosting of a UPC division. The Italian government is keen for Milan to be a seat for UPC life sciences litigation.
“The choice of Milan as candidate for the third headquarters of the Unified Patent Court is a strategic decision,” it says, “in the direction of a further Italian contribution to the development and growth of the European Union.”
The argument picked up steam once the UK announced its withdrawal from the UPC project, leaving a gap for a pharmaceutical-specialist court. Milan is hosting a local division but is in the running, alongside Amsterdam, to host the now-vacant central division. In the interim period, courts in Paris and Munich are picking up the slack.
Many of Italy’s patent lawyers see the UPC as an opportunity for greater visibility of the Italian patent system in Europe. Its long-standing pharma tradition means sufficient technical expertise. Increased court openness, and more advanced English language skills, sees its judges better argue the case for Italy hosting a division – against, for example, Germany or the Netherlands.
Giovanni Ghirardi, partner at the Milan office of Hogan Lovells, says, “So far, Italy is underrepresented in the EU judicial landscape. But now we have specialised judges and we can ensure uniformity among judgments.”
Certainly, hosting a UPC would fit into the economic-centric vision of Italy’s new investment-ready government.
Gabriel Cuonzo says, “We had the impression that the former Italian government was very keen on Milan taking a more active role in the UPC. Let’s see how things unfold with the new government.”
“If these efforts were successful, the central pharma division in Milan might have beneficial spill-over effects on the Italian litigation system as a whole.”
Period of self-reflection
But, in some circles, the appetite for a UPC is waning. Giovanni Guglielmetti says, “German patent litigation is much better-positioned for a UPC than Italy. We are an ‘importer’ of litigation, with very few cases exported from Italy. Some lawyers are worried a UPC might lose them work.”
For other lawyers, streamlining of court procures means Italy is in the midst of a period of self-reflection. Now is a good time for the country’s patent system to take stock of what it can offer and prepare itself for further investment.
Gabriel Cuonzo says, “The use of technology in court proceedings is an important issue, and one which our courts historically fell behind. Now, Italy is keeping things in-line with international standards.”
Some lawyers say there should be a level of uniformity before the UPC. If the pan-European court is to start, it needs judges to be close to the business issue and make business-focused decisions. But some experts express doubts that Italy is not yet in a position to do this.
Land where lemons grow
Undoubtedly, life sciences litigation continues to drive the Italian patent market. Mix in trade secrets expertise, its strong reputation for cases involving mechanical patents, and its future as a forum for standard essential patent cases, and Italy’s patent future looks bright.
The optimism of its patent lawyers buoys the market, who almost unanimously consider Italy – and especially Milan – the next major seat of European patent litigation.
Brexit means the UK has created a vacuum for the potential UPC pharmaceutical division, as well as for European firms looking to consolidate their offering. As the Italian patent market grows is strength, so too does its viability as a main player in European patent litigation. (Co-author: Mathieu Klos)
Cicc8: the sustainable beach fork holder!
Luca Silipo has designed Cicc8, a ‘beach fork holder’ made entirely of simple, cheap and ecological materials to protect the environment
“Every time I went to the beach I saw an exaggerated number of cigarette butts left on the sand. Since our company produces paper bags, I thought of making a small bag to collect the butts without polluting the environment”. This is how Luca Silipo got the inspiration to create Cicc8, the beach cigarette butt holder. The device is made entirely of eco-friendly materials and looks like a normal aluminium bag. By folding it, the air is removed and the butt inside the bag is extinguished due to lack of oxygen. In this way, we can be sure that the cigarette is extinguished and does not pollute the environment.
You might also be interested in –> Apimires: high-tech help for beekeepers and the environment
Cicc8: the beach ashtray
The ashtray can be “branded” with the name of one or more sponsors, perhaps bathing establishments or environmental associations, and become an effective means of advertising and raising awareness of environmental issues. In addition to the beach, Cicc8 can also be used in parks, gardens or nature reserves. In short, wherever there is a need for a system to collect cigarette butts in a simple, ecological and economical way. The cost of a 360-piece dispenser is around €25: 5 cents for each Cicc8!
Read also —> Xiaomi Smart Glasses for mental health and wellness
E-NNOVATE 2021: the International Invention Show returns online 23-25 June
The second edition of E-NNOVATE International Invention Show will take place online from June 23th-25th: registration open now
E-NNOVATE was conceptualised to provide a blend the real-world innovation event experience with the virtual world and making it possible for the innovator to reach a larger audience in a very convenient effective and economic way by introducing Virtual Booths alongside the Traditional Booths. E-NNOVATE is not just a platform, it is an ecosystem of like minded people willing to create a great impact in the innovation space with synergy. Being a digital platform E-NNOVATE has tremendous reach which will propel the innovative ideas to the farthest corners of the world.
Traditional & Virtual Booths
With E-NNOVATE, the participants can register in both TRADITIONAL and VIRTUAL BOOTHS.
E-NNOVATE is a fantastic global one-stop-destination for innovators, technology buyers and enthusiasts alike.
E-NNOVATE gives the innovators an opportunity to present their innovations and discuss with reputed jury members across the globe.
Apart from the world class experience and opportunity to showcase their innovations to the world, the participants in E-NNOVATE are also entitled to various exciting benefits as follows:
- Top 1 contestant will get a chance to participate in IBS Designnovate 2021 conference free of cost!
- Top 3 contestants get a chance to participate in IIIF 2021 free of cost!
- Top 10 contestants get a chance to promote their innovations on iTechBazaar Innovation portal for 1 year! Free of cost!
- Top 10 contestants will get an opportunity to promote their innovations on IBS Social media handles twice a year! Free of cost!
Corning and Schott battle over flexible glass handset displays
The European Patent Office has revoked EP 30 99 644, owned by US manufacturer Corning, which covers the production of flexible glass for use in mobile devices. Schott had previously filed an opposition against the patent. However, in January 2021 an EPO opposition proceeding revoked EP 644 because the patent and the invention were found to not meet European Patent Convention requirements.
According to JUVE Patent information, the EPO Opposition Division had doubts about the lack of reproducibility of Coning’s bendable glass. The US company can appeal the decision to the EPO Boards of Appeal.
Corning had already lost a second patent in May 2020, after Schott successfully challenged the grant of EP 30 99 643. In summer, Corning then filed an appeal against the decision of the EPO Opposition Division (case ID: T 1521/20-3.3.06). The office has not yet set a date for the oral hearing.
But a further opposition hearing by Schott against a third patent of Corning will take place on 26 April. The patent in question, EP 30 99 642, protects the manufacturing of stack assemblies in bendable glass.
Flexible glass for the future
Bendable displays are considered a key technology for mobile devices. Korean handset giant Samsung Electronics was one of the first in the market to offer foldable mobile phones. Samsung’s Galaxy Z Flip and Galaxy Z Fold 2 phones use this bendable Ultra Thin Glass (UTG) developed by Samsung Display. Schott is the exclusive supplier of Samsung Display.
According to media reports, other handset makers from China and the US are currently working on foldable mobile phones.
Samsung Electronics is the world’s largest manufacturer of mobile devices, with Samsung Display belonging to the same Korean parent company. However, the two do not necessarily work together in device production. As recently reported by several media outlets, Samsung Electronics wants to develop its own display glass for future generations of its foldable smartphones. Here, the company wants to work together with US company Corning.
Corning is best known for its very safe Gorilla Glass, used in many mobile devices. The US company started developing bendable display glass later than Schott.
Corning and Schott are not only fierce competitors in the field of bendable glass. Schott has also challenged another European patent owned by Corning, covering another technology. However, JUVE Patent is not aware of any further cases between the two opponents.
German and UK patent firms in the lead
Corning had previously filed its new flexible glass technology in the US, before bringing it over to Europe. The company regularly uses UK patent attorney firm Elkington & Fife for European applications, including EP 642, EP 643 and EP 644. Corning also works with a German and French patent attorney firm on EPO applications.
However, when Schott opposed the grant of EP 642, EP 643 and EP 644, Corning changed its advisors. Robert Sackin of UK firm Reddie & Grose now leads the defence of the patents.
Schott attacked the three Corning patents with the help of Markus Rieck, of German patent attorney firm Fuchs. The Frankfurt-based firm regularly works for the German glass product manufacturer. The latter also engages other German patent attorney firms for patent fillings.
Reddie & Grose (Cambridge): Robert Sackin (patent attorney)
Fuchs (Frankfurt): Markus Rieck, Florian Rüssmann (both patent attorneys)
In-house (Mainz): Axel Curdt and Dagmar Burda (both patent attorneys)
TPB Acquisition I files for a $250 million IPO; SPAC targets sustainable food production
Elliott Management’s tech-focused SPAC Elliott Opportunity I files for a $1.0 billion IPO
Litecoin Price Analysis: 20 February
VeChain Review: Blockchain Supply Chain Management
S3 AeroDefense Signs 10 Year Distribution Agreement & Repair License with Honeywell Aerospace
Special purpose acquisition companies grow in popularity on Wall Street during the pandemic
Why MicroStrategy and other institutions don’t regret their Bitcoin buys
Why retail adoption of Bitcoin may be a challenge at $55,000
Paul Singer-backed blank-check firms file for up to $1.5 billion IPO
Perseverance sends back post-touchdown selfie
Chainlink integrates with Danal Fintech to support retail Bitcoin payments
Tesla’s Gigafactory formula rose from a humble “tent” at the Fremont Factory
Are Bitcoin’s long-term hodlers entering the seller’s market?
Polkadot, Cosmos, IOTA Price Analysis: 20 February
Super-light laptop carries heavyweight price tag
SEC is “dead wrong” in the Ripple case claims former SEC chair Mary Jo White
Chainlink, Aave, SushiSwap Price Analysis: 20 February
Litecoin, EOS, Decred Price Analysis: 20 February
Ethereum Price Analysis: 20 February
Binance coin, Tron, FTX Token Price Analysis: 20 February
Gaming1 week ago
Super Mario 3D World + Bowser’s Fury Debuts on Top of UK Charts With 3x Sales of the Original
PR Newswire6 days ago
Abound Raises $22.9 Million In Series A Financing To Accelerate Growth, Enhance Tech Offerings, Further International Expansion
Bioengineer1 week ago
UTIA Professor receives SAEA Emerging Scholar Award
AI1 week ago
Building an omnichannel Q&A chatbot with Amazon Connect, Amazon Lex, Amazon Kendra, and the open-source QnABot project
Blockchain1 week ago
Top 10 Most Expensive Things Bought with Bitcoin
Cleantech6 days ago
Perseverance touches down on the red planet
Crowdfunding1 week ago
Alchemy Pay Teams Up With Power-Bank-Sharing Network Instpower to Enable Digital Payment Acceptance Across Charging Stations
Amb Crypto6 days ago
BRD Wallet announces Tezos staking following integration
Amb Crypto1 week ago
How Bitcoin investors are managing the asset’s volatility
Amb Crypto1 week ago
The economic cost of a bitcoin & crypto ban in India
Crowdfunding1 week ago
Global Digital Finance Broadly Agrees with Hong Kong Proposal to Regulate VASPs but Worries that Blocking Retail from Crypto is Wrong Move
Bioengineer1 week ago
Parents Say COVID-19 has disrupted children’s dental care